Depression, selective serotonin reuptake inhibitors and osteoporosis

Current Osteoporosis Reports

Volumn 8, Issue 4, 2010, Pages 185-191

  Bab, Itai ^b   Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

Adrenergic signaling; Antidepressant; Bone loss; Bone mass; Bone remodeling; Depression; Fracture; Glucocorticoids; Major depressive disorder; Norepinephrine; Osteoblast; Osteocyte; Osteoporosis; Selective serotonin reuptake inhibitors; Serotonin; Serotonin receptors; Serotonin transporter; Sympathetic nervous system

Indexed keywords

CORTICOSTEROID; ESTROGEN; GLUCOCORTICOID; IMIPRAMINE; NORADRENALIN; PROPRANOLOL; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

BONE DENSITY; BONE DISEASE; BONE MASS; BONE REMODELING; CELL ACTIVITY; CORTICOSTEROID BLOOD LEVEL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FRAGILITY FRACTURE; HUMAN; MENTAL DISEASE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PREMENOPAUSE; PROTEIN TARGETING; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; SYMPATHETIC INNERVATION;

ANIMALS; BONE AND BONES; BONE DENSITY; CAUSALITY; COMORBIDITY; DEPRESSION; HUMANS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, SEROTONIN; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 77958111179     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-010-0026-z     Document Type: Review

References (48)

1. R Yirmiya I Bab 2009 Major depression is a risk factor for low bone mineral density: a meta-analysis Biol Psychiatry 66 423 432 10.1016/j.biopsych. 2009.03.016 19446797 This article reports the most comprehensive meta-analysis demonstrating a significant correlation between MDD and low bone mass, which is stronger in women than in men and in pre- than postmenopausal women. The article further provides a review of the studies dealing with depression and bone and portrays depression as a risk factor for osteoporosis
2. CJ Murray AD Lopez 1997 Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1498 1504 1:STN:280:DyaK2szhtVaqsw%3D%3D 10.1016/S0140-6736(96)07492-2 9167458 (Pubitemid 27216360)
3. BL Riggs S Khosla LJ Melton 3rd 2002 Sex steroids and the construction and conservation of the adult skeleton Endocr Rev 23 279 302 1:CAS:528:DC%2BD38XltlWjtrs%3D 10.1210/er.23.3.279 12050121 (Pubitemid 34651948)
4. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Arlington, VA: American Psychiatric Association; 1994.
5. G Cizza S Primma M Coyle, et al. 2010 Depression and osteoporosis: a research synthesis with meta-analysis Horm Metab Res 42 467 482 1:CAS:528:DC%2BC3cXpsVOlur0%3D 10.1055/s-0030-1252020 20455194 This study shows that the low BMD is associated with MDD and involves the anterior-posterior spine, femoral neck, and total femur, suggesting that depression-associated low bone mass is site independent
6. Q Wu JH Magnus J Liu, et al. 2009 Depression and low bone mineral density: a meta analysis of epidemiologic studies Osteoporos Int 20 1309 1320 1:STN:280:DC%2BD1MvnsVKrtA%3D%3D 10.1007/s00198-009-0918-x 19343469 This meta-analysis found that depression is associated with a significantly decreased BMD, with a substantially lower BMD in depressed women and in cases of clinical depression
7. R Yirmiya I Goshen A Bajayo, et al. 2006 Depression induces bone loss through stimulation of the sympathetic nervous system Proc Natl Acad Sci U S A 103 16876 16881 1:CAS:528:DC%2BD28Xht1egurvN 10.1073/pnas.0604234103 17075068 Using CMS, a mouse model for depression, this article suggests a causal relationship whereby depression induces bone loss, mainly by inhibiting bone formation. The article further portrays the sympathetic nervous system as the main pathway communicating depressive signals to the skeleton (Pubitemid 44737346)
8. LD Dorn EJ Susman S Pabst, et al. 2008 Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls Arch Pediatr Adolesc Med 162 1181 1188 10.1001/archpedi.162.12. 1181 19047547 Consistent with the increased association between depression and low bone mass in premenopausal women, this article demonstrates an association between depressive symptoms and low bone density in adolescent girls, implicating depression in the inhibition of bone mass accrual
9. DT Gold S Solimeo 2006 Osteoporosis and depression: a historical perspective Curr Osteoporos Rep 4 134 139 10.1007/s11914-996-0021-6 17112423 (Pubitemid 46030450)
10. I Ilias S Alesci PW Gold GP Chrousos 2006 Depression and osteoporosis in men: association or casual link? Hormones (Athens) 5 9 16
11. RS Weinstein RL Jilka AM Parfitt SC Manolagas 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone J Clin Invest 102 274 282 1:CAS:528:DyaK1cXkslOktrc%3D 10.1172/JCI2799 9664068
12. F Elefteriou 2008 Regulation of bone remodeling by the central and peripheral nervous system Arch Biochem Biophys 473 231 236 1:CAS:528: DC%2BD1cXlsFOgur0%3D 10.1016/j.abb.2008.03.016 18410742
13. XY Lu 2007 The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 7 648 652 1:CAS:528: DC%2BD2sXhtlyksrnE 10.1016/j.coph.2007.10.010 18032111 (Pubitemid 350177558)
14. G Karsenty 2006 Convergence between bone and energy homeostases: leptin regulation of bone mass Cell Metab 4 341 348 1:CAS:528:DC%2BD28Xht1aksrnO 10.1016/j.cmet.2006.10.008 17084709 (Pubitemid 44645074)
15. J Tam V Trembovler V Di Marzo S Petrosino, et al. 2008 The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling FASEB J 22 285 294 1:CAS:528:DC%2BD1cXkslWmsw%3D%3D 10.1096/fj.06-7957com 17704191
16. MN Hill EJ Carrier RJ McLaughlin, et al. 2008 Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment J Neurochem 106 2322 2336 1:CAS:528:DC%2BD1cXhtFOit7jF 10.1111/j.1471-4159.2008.05567.x 18643796
17. A Bajayo I Goshen S Feldman, et al. 2005 Central IL-1 receptor signaling regulates bone growth and mass Proc Natl Acad Sci U S A 102 12956 12961 1:CAS:528:DC%2BD2MXhtVWktbzN 10.1073/pnas.0502562102 16126903 (Pubitemid 41279471)
18. I Goshen T Kreisel O Ben-Menachem-Zidon, et al. 2008 Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol Psychiatry 13 717 728 1:CAS:528:DC%2BD1cXnt1alt7w%3D 10.1038/sj.mp.4002055 17700577 (Pubitemid 351861529)
19. UC Adler AH Marques HM Calil 2008 Inflammatory aspects of depression Inflamm Allergy Drug Targets 7 19 23 1:CAS:528:DC%2BD1cXmslKrsrY%3D 10.2174/187152808784165216 18473896 (Pubitemid 351688296)
20. GR Mundy 2007 Osteoporosis and inflammation Nutr Rev 65 S147 S151 10.1301/nr.2007.dec.S147-S151 18240539
21. B Yu J Becnel M Zerfaoui, et al. 2008 Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency J Pharmacol Exp Ther 327 316 323 1:CAS:528: DC%2BD1cXhtlWns7zE 10.1124/jpet.108.143461 18708586
22. C Roggia Y Gao S Cenci, et al. 2001 Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo Proc Natl Acad Sci U S A 98 13960 13965 1:CAS:528: DC%2BD3MXovVynuro%3D 10.1073/pnas.251534698 11717453 (Pubitemid 33116006)
23. MF Poirier O Canceil F Baylé, et al. 2002 Prevalence of smoking in psychiatric patients Prog Neuropsychopharmacol Biol Psychiatry 26 529 537 10.1016/S0278-5846(01)00304-9 11999904 (Pubitemid 34252947)
24. O Klungsøyr JF Nygård T Sørensen I Sandanger 2006 Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study Am J Epidemiol 163 421 432 10.1093/aje/kwj058 16394201
25. TL Steuber F Danner 2006 Adolescent smoking and depression: which comes first? Addict Behav 31 133 136 10.1016/j.addbeh.2005.04.010 15922514 (Pubitemid 41790455)
26. M Lorentzon D Mellström E Haug C Ohlsson 2007 Smoking is associated with lower bone mineral density and reduced cortical thickness in young men J Clin Endocrinol Metab 92 497 503 1:CAS:528:DC%2BD2sXitVaksLs%3D 10.1210/jc.2006-1294 17077132
27. P Gerdhem KJ Obrant 2002 Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound Osteoporos Int 13 932 936 1:STN:280:DC%2BD38npvVCjug%3D%3D 10.1007/s001980200130 12459935 (Pubitemid 36050270)
28. DA Chakkalakal 2005 Alcohol-induced bone loss and deficient bone repair Alcohol Clin Exp Res 29 2077 2090 10.1097/01.alc.0000192039.21305.55 16385177 (Pubitemid 43042798)
29. RT Turner JD Sibonga 2001 Effects of alcohol use and estrogen on bone Alcohol Res Health 25 276 281 1:STN:280:DC%2BD387nvVKrug%3D%3D 11910705
30. PA Zalloua YH Hsu H Terwedow, et al. 2007 Impact of seafood and fruit consumption on bone mineral density Maturitas 56 1 11 10.1016/j.maturitas.2006. 05.001 16806750 (Pubitemid 44914036)
31. WK Kroeze K Kristiansen BL Roth 2002 Molecular biology of serotonin receptors structure and function at the molecular level Curr Top Med Chem 2 507 528 1:CAS:528:DC%2BD38Xksl2jt70%3D 10.2174/1568026023393796 12052191
32. JR Raymond YV Mukhin A Gelasco, et al. 2001 Multiplicity of mechanisms of serotonin receptor signal transduction Pharmacol Ther 92 179 212 1:CAS:528:DC%2BD38Xitlejs7s%3D 10.1016/S0163-7258(01)00169-3 11916537 (Pubitemid 34251133)
33. NJ Talley 2001 Serotoninergic neuroenteric modulators Lancet 358 2061 2068 1:STN:280:DC%2BD38%2FktlCjtw%3D%3D 10.1016/S0140-6736(01)07103-3 11755632 (Pubitemid 34084835)
34. PR Wade J Chen B Jaffe, et al. 1996 Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract J Neurosci 16 2352 2364 1:CAS:528:DyaK28XhvVCksr8%3D 8601815
35. A McNicol SJ Israels 1999 Platelet dense granules: structure, function and implications for haemostasis Thromb Res 95 1 18 1:CAS:528:DyaK1MXksVSrtLk%3D 10.1016/S0049-3848(99)00015-8 10403682 (Pubitemid 29325256)
36. P Egermayer GI Town AJ Peacock 1999 Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax 54 161 168 1:STN:280:DyaK1M3lslOksQ%3D%3D 10.1136/thx.54.2.161 10325923
37. SL Lee WW Wang JJ Lanzillo BL Fanburg 1994 Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture Am J Physiol 266 L46 L52 1:CAS:528:DyaK2cXhvVeksr8%3D 8304469
38. SJ Warden MM Bliziotes KM Wiren, et al. 2005 Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine) Mol Cell Endocrinol 242 1 9 1:CAS:528:DC%2BD2MXhtVGrsbnE 10.1016/j.mce.2005.06.005 16085354 (Pubitemid 41393704)
39. PP Cherian B Cheng S Gu, et al. 2003 Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor J Biol Chem 278 43146 43156 1:CAS:528:DC%2BD3sXosFSkur8%3D 10.1074/jbc.M302993200 12939279 (Pubitemid 37345933)
40. M Bliziotes A Eshleman B Burt-Pichat, et al. 2006 Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells Bone 39 1313 1321 1:CAS:528:DC%2BD28Xht1KrsbrN 10.1016/j.bone.2006.06.009 16884969 (Pubitemid 44827920)
41. M Rand G Reid 1951 Source of 'serotonin' in serum Nature 168 385 1:CAS:528:DyaG3sXivFShtQ%3D%3D 10.1038/168385b0 14875097
42. VK Yadav J-H Ryu N Suda, et al. 2008 Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum Cell 135 825 837 1:CAS:528:DC%2BD1cXhsV2jtr%2FP 10.1016/j.cell.2008.09.059 19041748 This article shows that gut-derived 5-HT reaches bone via the blood circulation and inhibits osteoblast proliferation, bone formation, and bone density by activating osteoblastic Htr1b receptor and CREB. It is the first report implicating gut- rather than bone cell-derived 5-HT in the regulation of skeletal remodeling
43. VK Yadav S Balaji PS Suresh, et al. 2010 Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis Nat Med 16 308 312 1:CAS:528:DC%2BC3cXhs1Olsr4%3D 10.1038/nm.2098 20139991
44. C Collet C Schiltz V Geoffroy, et al. 2008 The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation FASEB J 22 418 427 1:CAS:528:DC%2BD1cXhvVSqsb0%3D 10.1096/fj.07-9209com 17846081 This article reports a low bone mass phenotype in female Htr2b receptor null mice, due to restrained osteoblast recruitment. Compared with Yadav et al. [42••], these findings suggest an opposite skeletal role for 5-HT, namely, stimulation of bone formation and bone mass. (Pubitemid 351225578)
45. BI Gustafsson I Westbroek JH Waarsing, et al. 2006 Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats J Cell Biochem 97 1283 1291 1:CAS:528:DC%2BD28XjtFeqtLk%3D 10.1002/jcb.20733 16329113
46. N Bonnet P Bernard H Beaupied, et al. 2007 Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling Toxicol Appl Pharmacol 221 111 118 1:CAS:528: DC%2BD2sXltF2ks7o%3D 10.1016/j.taap.2007.02.005 17383703 (Pubitemid 46711209)
47. VK Yadav F Oury N Suda, et al. 2009 A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure Cell 138 976 989 1:CAS:528:DC%2BD1MXhsVCjs7zP 10.1016/j.cell.2009.06.051 19737523 This article shows that 5-HT in the brain downregulates the skeletal antianabolic sympathetic tone, thus assigning opposite skeletal effects to central and peripheral 5-HT signaling
48. G Ziere JP Dieleman TJ van der Cammen, et al. 2008 Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures J Clin Psychopharmacol 28 411 417 1:CAS:528: DC%2BD1cXosFWgt7c%3D 10.1097/JCP.0b013e31817e0ecb 18626268